The article discusses Walgreens’ latest venture into the clinical trials business through a new partnership with Parexel, a contract research organization (CRO). Walgreens aims to leverage its vast network of retail locations to provide convenient access for patients participating in clinical trials. This move follows Walgreens’ previous partnership with PRA Health Sciences in the same field.
The article notes that these developments reflect the growing interest among pharmacies and healthcare organizations in the clinical trials space. By incorporating clinical trials into their services, Walgreens and other organizations seek to enhance patient engagement, provide broader access to research opportunities, and contribute to medical advancements.